Real-time enrollment status for this type 2 diabetes clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT06628362 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Type 2 Diabetes |
| Phase | Clinical Trial |
| Target Enrollment | 360 participants |
| Active Locations | 63 sites in the US |
| Sponsor | Carmot Therapeutics, Inc. |
| Last Updated on CT.gov | January 7, 2026 (Jan 7, 2026) |
As of March 2, 2026: Clinical trial NCT06628362 is currently active_not_recruiting participants. This clinical trial study for type 2 diabetes is not currently accepting new participants at 63 locations across the United States. The study is sponsored by Carmot Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06628362 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 63 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06628362 was last updated Jan 7, 2026 (January 7, 2026). HelloStudys verifies this status automatically.